Amgen Inc at UBS Global Healthcare Conference Transcript
(technical difficulty)
Here at UBS talking on the Day 2 of our Global Healthcare Conference. I'm pleased to invite Amgen to the stage here. Joining the company, Dr. Elliott Levy, Senior Vice President of Global Development; as well as Arvind Sood, Head of IR. For Amgen, we're going to have an active Q&A here. We've got a good list of questions to dive into, no shortage of topics, especially ahead of ASCO.
If you have any questions you'd like to ask, feel free to use the UBS app and they will magically appear here and we will try to make an effort to go through them. Prior to kicking things off, though, I think Arvind, you're going to make some opening comments?
Yes. I see that our one and only slide show it up, so I'm pleased to see that. I mean this is often advertised as a fireside chat. There's a lot of chatting, but you never see the fireside. So anyway here we are.
So Carter, first of all, thanks for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
